25 May 2013
Keywords: xeloda, nda, backed, fda, advisory, panel, oncologic
Article | 20 March 1998
The Oncologic Drugs Advisory Committee to the US Food and DrugAdministration has recommended approval of Hoffmann-La Roche's Xeloda
(capecitabine) for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 March 1998
19 March 1998
24 May 2013
© 2013 thepharmaletter.com